Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Financial Disclosure

Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents Financial Disclosure (Reporting Period: February 2018 to February 2019)
Panel Member Status Company (Relationship)
Judith Aberg M
  • Frontier Biotechnologies (Research Support)
  • Gilead (Research Support)
  • Janssen (Advisory Board)
  • Merck (Advisory Board)
  • ViiV (Advisory Board, Research Support)
Adaora Adimora M
  • Gilead (Consultant, Research Support)
  • Merck (Advisory Board)
  • ViiV (Consultant).
Allison Agwu M
  • Gilead (Advisory Board)
  • Merck (Advisory Board)
Jason Baker M None
Curt Beckwith M
  • Gilead (Research Support)
Roger Bedimo M
  • Merck (Advisory Board, Research Support)
  • Napo Pharmaceuticals (Consultant)
  • ViiV (Advisory Board, Research Support)
John T. Brooks
M None
R. Douglas Bruce M None
Danielle Campbell M
  • Gilead (Advisory Board)
Geetanjali Chander M None
Laura Cheever M None
Jennifer Cocohoba M None
Susan Cu-Uvin M None
Eric Daar M
  • Gilead (Consultant, Research Support)
  • Merck (Research Support)
  • ViiV (Research Support)
David Evans M
  • Gilead (Travel Support)
  • Merck (Travel Support)
  • ViiV (Travel Support)
Rajesh Gandhi M
  • Gilead (Advisory Board)
  • Merck (Advisory Board)
Edward Gardner M None
Thomas Giordano M None
David Glidden M
  • Gilead (Advisory Board)
Linda Gorgos M
  • AbbVie (Research Support)
  • Gilead (Research Support)
  • Merck (Research Support)
  • Proteus (Research Support)
  • Janssen (Research Support)
Roy M. Gulick C None
Birgit Grund M None
Tim Horn M None
Peter Hunt M
  • Gilead (Honoraria, Research Support)
  • Janssen (Honoraria)
  • ViiV (Consultant)
Emily Hyle M None
Steven Johnson M None
Rami Kantor M None
Andy Kaytes M
  • ViiV (Travel Support)
  • CytoDyn (Advisory Board, Honoraria)
Marla J. Keller M None
Arthur Kim M None
Michael Kozal M
  • Gilead*
  • ViiV*
* Yale University receives grant support from these companies for studies where Dr. Kozal served or serves as PI. Dr. Kozal is an employee of the federal government and does not receive any financial support from these grants.
H. Clifford Lane C None
Jeffrey Lennox M
  • Gilead (Advisory Board)
  • ViiV (Research Support)
Henry Masur M None
Susanna Naggie M
  • AbbVie (Research Support)
  • BioMarin (Advisory Board)
  • Bristol-Myers Squibb (Event Adjudication Committee)
  • Gilead (Research Support)
  • Tacere Therapeutics (Research Support)
  • Vir Biotechnology (Advisory Board)
Alice K. Pau ES None
Tonia Poteat M
  • Gilead (Advisory Board, Research Support)
  • ViiV (Research Support)
Asa Radix M None
James Raper M None
Daniel Reirden M
None
Kimberly Scarsi M None
Virginia Sheikh M None
Serena Spudich M None
Kimberly Struble M None
Susan Swindells M
  • ViiV (Research Support)
Pablo Tebas M
  • Gilead (Research Support, Consultant)
  • Inovio Pharmaceuticals (Research Support)
  • Janssen (Research Support)
  • Merck (Research Support, Consultant)
  • ViiV (Research Support, Consultant)
Melanie Thompson M
  • Bristol-Myers Squibb (Research Support)
  • CytoDyn, Inc. (Research Support)
  • Frontier Biotechnologies (Research Support)
  • Gilead (Research Support)
  • GlaxoSmithKline (Research Support)
  • Merck, Sharpe, Dohme, Inc. (Research Support)
  • ViiV (Research Support)
Phyllis Tien M
  • Merck (Research Support)
  • Theratechnologies (Research Support)
Steven Vargas M
  • ViiV (Honoraria)
Rochelle Walensky M None
Key: C = Co-Chair; ES = Executive Secretary; M = Member; PI = Principal Investigator

Download Guidelines